SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-036000
Filing Date
2022-12-20
Accepted
2022-12-20 16:11:13
Documents
80
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1003439
2 ex31-1.htm EX-31.1 17851
3 ex31-2.htm EX-31.2 17703
4 ex32-1.htm EX-32.1 6678
5 ex32-2.htm EX-32.2 6404
  Complete submission text file 0001493152-22-036000.txt   5708698

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE vvos-20220930.xsd EX-101.SCH 45689
7 XBRL CALCULATION FILE vvos-20220930_cal.xml EX-101.CAL 69195
8 XBRL DEFINITION FILE vvos-20220930_def.xml EX-101.DEF 155839
9 XBRL LABEL FILE vvos-20220930_lab.xml EX-101.LAB 353453
10 XBRL PRESENTATION FILE vvos-20220930_pre.xml EX-101.PRE 283594
74 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 927429
Mailing Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120
Business Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120 (866)908-4867
Vivos Therapeutics, Inc. (Filer) CIK: 0001716166 (see all company filings)

IRS No.: 813224056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39796 | Film No.: 221474902
SIC: 3841 Surgical & Medical Instruments & Apparatus